Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.
Research demonstrates that using personalized fMRI resting-state scans to target transcranial magnetic stimulation (TMS) increases depression response rates to 80%, compared to 60% with standard scalp-based targeting. The accelerated protocol offers potential faster treatment timelines (one week) for patients with treatment-resistant depression.
Research demonstrates that systemic bodily inflammation alters brain function and can trigger depression-like symptoms and sickness behavior, particularly during acute infections and chronic autoimmune conditions. The study explores the biological mechanisms linking peripheral inflammation to central nervous system effects.
A randomized clinical trial from Mass General Brigham demonstrates that using personalized brain imaging to tailor transcranial magnetic stimulation (TMS) treatment may enhance outcomes for patients with treatment-resistant depression. The findings, published in JAMA Psychiatry, suggest individualized neuroimaging-guided approaches could improve the efficacy of this FDA-approved therapeutic intervention.
Olfactory and gustatory disorders are associated with significant psychological, emotional, and social distress comparable in impact to serious chronic conditions such as stroke, diabetes, and Parkinson's disease. The loss of these senses can substantially affect quality of life and mental health outcomes.
This editorial examines the intricate connections between neurocognitive disorders and depression, highlighting how these conditions frequently co-occur and influence one another. The piece addresses the clinical and research implications of understanding these interrelationships for improved patient assessment and treatment approaches.
